B+
Bull case
25%
Probability
Target price
$3.70
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
PLX
Protalix BiotherapeuticsANYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Second-quarter product revenue rose to $19.8 million, primarily driven by Elfabrio sales, while Protalix reiterated 2026 revenue guidance. Continued commercial growth and favorable PRX-115 trial progress could support upside.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
Limited analyst coverage and loose equity peers weaken target-based valuation checks.
Momentum
98
Value
64
Sentiment
70
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.80 · Bull $3.70 · Bear $1.60Analysis 2026-10-25; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-25 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $11.00
Why
Momentum98 · Δ7d -
Value64 · Δ7d +0.0
Sentiment70 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite.
Contradictions & invalidation
- • Limited analyst coverage and loose equity peers weaken target-based valuation checks.
- • PRX-115 enrollment, efficacy and safety remain uncertain before the anticipated second-half 2027 Phase 2 readout. [#SEC-8K-2026-08-12]
- • First-half revenue includes a $25 million milestone, limiting what headline growth says about recurring demand.
Catalyst clock
2026-12-31
Delivery of 2026 revenue guidance
Lead driver: Sentiment · See AI snapshot
Momentum
98
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
64
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.4
Sentiment
70
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 98.3 / Value 64.0 / Sentiment 70.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-25. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$2.80
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$1.60
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$205.46M
Beta
-0.21
Shares Out
80.57M
P/E (TTM)
38.8
P/S (TTM)
2.33
P/FCF (TTM)
19.47
Rev YoY
+27.1%
EPS YoY
+2190.0%
Gross Margin
+69.2%
Op Margin
+28.9%
Net Debt
-$22.65M
Current Ratio
2.94
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data